Levetiracetam and Mucosal dryness - a phase IV clinical study of FDA data
Summary:
Mucosal dryness is reported as a side effect among people who take Levetiracetam (levetiracetam), especially for people who are male, 60+ old, also take Acetylsalicylic Acid, and have Metastatic malignant melanoma.
The phase IV clinical study analyzes which people have Mucosal dryness when taking Levetiracetam. It is created by eHealthMe based on reports of 74,747 people who have side effects when taking Levetiracetam from the FDA, and is updated regularly.
What is Levetiracetam?
Levetiracetam has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 75,292 Levetiracetam users. Check the latest studies of Levetiracetam.
What is Mucosal dryness?
Mucosal dryness (dryness of mucous membrane) is found to be associated with 370 drugs and 465 conditions by eHealthMe. Check the latest studies of Mucosal dryness.
74,747 people reported to have side effects when taking Levetiracetam.
Among them, 34 people (0.05%) have Mucosal dryness.

Among these 34 people:
What is the gender of people who have Mucosal dryness when taking Levetiracetam? *
- female: 33.33 %
- male: 66.67 %
What is the age of people who have Mucosal dryness when taking Levetiracetam? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 28.12 %
- 30-39: 0.0 %
- 40-49: 3.12 %
- 50-59: 3.12 %
- 60+: 65.62 %
What are other drugs people take besides Levetiracetam? *
- Acetylsalicylic Acid: 20 people, 58.82%
- Pantoprazole: 18 people, 52.94%
- Vimpat: 14 people, 41.18%
- Movicol: 14 people, 41.18%
- Lorazepam: 5 people, 14.71%
- Propofol: 5 people, 14.71%
- Gabapentin: 5 people, 14.71%
- Fentanyl: 5 people, 14.71%
- Dilantin: 3 people, 8.82%
- Dexamethasone: 1 person, 2.94%
What are other side effects people have besides Mucosal dryness? *
- Peripheral Motor Neuropathy (muscles in the body become progressively weaker over months to years): 23 people, 67.65%
- Peripheral Sensory Neuropathy (damage to one or more of your peripheral nerves): 23 people, 67.65%
- Fatigue (feeling of tiredness): 23 people, 67.65%
- Peripheral Nerve Lesion: 22 people, 64.71%
- Skin Hypopigmentation (loss of skin colour): 22 people, 64.71%
- Pain In Extremity: 22 people, 64.71%
- Conjunctivitis (pink eye): 22 people, 64.71%
- Hyperkeratosis (thickening of the outer layer of the skin): 22 people, 64.71%
- Epidural Lipomatosis (excessive accumulation of fat within the epidural space -brain): 22 people, 64.71%
- Photosensitivity Reaction: 22 people, 64.71%
What are the existing conditions these people have? *
- Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 23 people, 67.65%
- Metastases To Central Nervous System (cancer spreads to central nervous system): 22 people, 64.71%
- Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 22 people, 64.71%
- High Blood Pressure: 22 people, 64.71%
- Procedural Vomiting: 22 people, 64.71%
- Procedural Nausea: 22 people, 64.71%
- Procedural Headache: 22 people, 64.71%
- Malignant Melanoma (skin cancer rises from melancytes): 21 people, 61.76%
- Vision Blurred: 20 people, 58.82%
- Pain: 20 people, 58.82%
* Approximation only. Some reports may have incomplete information.
Do you take Levetiracetam and have Mucosal dryness?
- Check whether Mucosal dryness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Levetiracetam:
- Levetiracetam (75,292 reports)
Mucosal dryness treatments and more:
- Mucosal dryness (2,332 reports)
How severe was Mucosal dryness and when was it recovered:
Expand to all the drugs that have ingredients of levetiracetam:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Levetiracetam:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Mucosal dryness:
- Mucosal dryness (370 drugs)
Browse all the conditions that are associated with Mucosal dryness:
- Mucosal dryness (465 conditions)
Related publications that referenced our studies
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on levetiracetam (the active ingredients of Levetiracetam) and Levetiracetam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Crestor cause Polyneuropathy? - 2 seconds ago
- Could Neurontin cause Otitis Media? - 4 seconds ago
- Drug interactions of Gliclazide and Desonide - 5 seconds ago
- Could Zaroxolyn cause Cellulitis Aggravated? - 13 seconds ago
- Could Xywav cause Nausea And Vomiting? - 21 seconds ago
- Could Novocain cause Hallucinations? - 33 seconds ago
- Could Imdur cause Blood Pressure Diastolic Increased? - 34 seconds ago
- Could Alprazolam cause Hepatitis? - 38 seconds ago
- Could Clarithromycin cause Arrhythmias? - 43 seconds ago
- Could Cubicin cause Septic Embolus? - 44 seconds ago